GlaxoSmithKline PLC (LON:GSK) Investors: Morgan Stanley Keeps “Equal weight” Rating, Sees GBX 1700.00/Share; Pier Capital Raised Universal Display (OLED) Holding

July 18, 2017 - By Clifton Ray

GlaxoSmithKline PLC (LON:GSK) had its stock rating noted as “Equal weight” by analysts at Morgan Stanley. Morgan Stanley currently has a GBX 1700.00 target price on the 78.97B GBP market cap company or 5.80% upside potential. This was disclosed in a research report on 18 July.

Pier Capital Llc increased Universal Display Corp (OLED) stake by 22.83% reported in 2016Q4 SEC filing. Pier Capital Llc acquired 16,823 shares as Universal Display Corp (OLED)’s stock rose 58.84%. The Pier Capital Llc holds 90,505 shares with $5.10 million value, up from 73,682 last quarter. Universal Display Corp now has $5.76B valuation. The stock decreased 1.13% or $1.35 during the last trading session, reaching $118.3. About shares traded. Universal Display Corporation (NASDAQ:OLED) has risen 114.77% since July 18, 2016 and is uptrending. It has outperformed by 98.07% the S&P500.

Among 6 analysts covering Universal Display (NASDAQ:OLED), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Universal Display had 12 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Positive” rating given on Wednesday, February 15 by Susquehanna. The stock of Universal Display Corporation (NASDAQ:OLED) earned “Hold” rating by Canaccord Genuity on Wednesday, December 9. Gabelli upgraded the stock to “Buy” rating in Friday, November 4 report. On Monday, September 28 the stock rating was initiated by Summit Research with “Hold”. On Friday, February 24 the stock rating was maintained by Canaccord Genuity with “Hold”. The stock of Universal Display Corporation (NASDAQ:OLED) earned “Neutral” rating by Goldman Sachs on Friday, October 16. The firm earned “Hold” rating on Tuesday, August 11 by Zacks. The stock of Universal Display Corporation (NASDAQ:OLED) earned “Buy” rating by Goldman Sachs on Monday, May 23. Canaccord Genuity maintained Universal Display Corporation (NASDAQ:OLED) on Friday, November 4 with “Hold” rating. The stock of Universal Display Corporation (NASDAQ:OLED) earned “Hold” rating by Gabelli on Friday, May 6.

Pier Capital Llc decreased Cryolife Inc (NYSE:CRY) stake by 19,840 shares to 303,668 valued at $5.82M in 2016Q4. It also reduced Aspen Technology (NASDAQ:AZPN) stake by 7,771 shares and now owns 127,486 shares. Fabrinet (NYSE:FN) was reduced too.

Investors sentiment decreased to 1 in 2016 Q4. Its down 0.13, from 1.13 in 2016Q3. It is negative, as 36 investors sold OLED shares while 56 reduced holdings. 27 funds opened positions while 65 raised stakes. 30.39 million shares or 0.73% more from 30.17 million shares in 2016Q3 were reported. Hsbc Holdings Public Limited accumulated 7,147 shares or 0% of the stock. Pier Cap Limited Liability Corp, a Connecticut-based fund reported 90,505 shares. Menta Capital Limited Liability Corporation reported 0.05% of its portfolio in Universal Display Corporation (NASDAQ:OLED). Aqr Capital Management Ltd Liability holds 0% of its portfolio in Universal Display Corporation (NASDAQ:OLED) for 11,285 shares. Domini Impact Invs Ltd Liability Corp accumulated 9.57% or 4,889 shares. Avenir stated it has 2.33% in Universal Display Corporation (NASDAQ:OLED). Moreover, Price T Rowe Md has 0% invested in Universal Display Corporation (NASDAQ:OLED) for 24,114 shares. 1492 Capital Mngmt Limited Liability Company stated it has 6,012 shares or 0.26% of all its holdings. Quantitative Investment Limited Liability Corp holds 8,700 shares or 0.01% of its portfolio. Millennium Management Limited Liability Co owns 245,986 shares. Epoch Prtn has invested 0.79% in Universal Display Corporation (NASDAQ:OLED). Provise Mgmt Grp Ltd Limited Liability Company stated it has 0.06% in Universal Display Corporation (NASDAQ:OLED). Wells Fargo Co Mn stated it has 0.02% in Universal Display Corporation (NASDAQ:OLED). Legal And General Group Incorporated Public Limited has invested 0% in Universal Display Corporation (NASDAQ:OLED). Parallax Volatility Advisers Limited Partnership owns 2,911 shares for 0% of their portfolio.

Among 28 analysts covering GlaxoSmithKline PLC (LON:GSK), 9 have Buy rating, 4 Sell and 15 Hold. Therefore 32% are positive. GlaxoSmithKline PLC has GBX 2000 highest and GBX 1250 lowest target. GBX 1678.08’s average target is 4.52% above currents GBX 1605.5 stock price. GlaxoSmithKline PLC had 356 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating by BNP Paribas given on Thursday, August 4. On Tuesday, May 23 the stock rating was maintained by JP Morgan with “Neutral”. The firm earned “Buy” rating on Monday, October 17 by Bryan Garnier & Cie. Goldman Sachs maintained GlaxoSmithKline plc (LON:GSK) on Tuesday, January 24 with “Buy” rating. On Friday, September 16 the stock rating was maintained by JP Morgan with “Neutral”. The stock of GlaxoSmithKline plc (LON:GSK) earned “Buy” rating by Jefferies on Monday, February 13. The stock has “Underperform” rating by BNP Paribas on Wednesday, December 21. The stock has “Buy” rating by Beaufort Securities on Wednesday, March 30. The company was maintained on Friday, July 1 by BNP Paribas. Credit Suisse maintained it with “Neutral” rating and GBX 1440 target in Monday, June 27 report.

About 2.08M shares traded. GlaxoSmithKline plc (LON:GSK) has 0.00% since July 18, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: